Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delpazolid with Bedaquiline, Delamanid, and Moxifloxacin for Pulmonary Tuberculosis
NCT04550832Phase 2Completed
- Sponsor
- LigaChem Biosciences
- Start
- Oct 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of delpazolid in pulmonary tuberculosis (TB), sponsored by LigaChem Biosciences. Started Oct 2021; status: completed.
02
Drugs
delpazolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04550832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04550832.